Clinical trial

Foxiga Korea Local Phase 4 Study

NCT02564926

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-01-05

PhasePHASE4

Study timeline

Study start (actual)2016-01-05Date precision: day

Registry last updated2019-08-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Interventions

DapagliflozinDRUG · verified · RxNorm: dapagliflozin

GlimepirideDRUG · verified · RxNorm: glimepiride

Sponsors & collaborators

AstraZenecalead sponsor

Mapped research locations

SeoulSouth Korea4 IncheonSouth Korea1 DaeguSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02564926 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.